Orioles

Armstrong won't fight USADA charges, will lose Tour titles

Armstrong won't fight USADA charges, will lose Tour titles

Lance Armstrong's statement released Thursday night

USADA to strip Armstrong of Tour titles, ban for life

AUSTIN, Texas (AP) -- Lance Armstrong said Thursday night he is finished fighting a barrage of drug charges from the U.S. Anti-Doping Agency, putting his unprecedented string of seven Tour de France titles at risk along with his legacy as one of the greatest cyclists in history.

The decision sets up a likely lifetime ban from the sport and the possibility that Armstrong will be stripped of his signature achievement -- the extraordinary run of Tour titles he won from 1999-2005.

Armstrong, who retired last year, declined to enter arbitration -- his last option -- because he said he was weary of fighting accusations that have dogged him for years. He has consistently pointed to the hundreds of drug tests that he has passed as proof of his innocence.

"There comes a point in every man's life when he has to say, "Enough is enough." For me, that time is now," Armstrong said in a statement sent to The Associated Press. He called the USADA investigation an "unconstitutional witch hunt."

"I have been dealing with claims that I cheated and had an unfair advantage in winning my seven Tours since 1999," he said. "The toll this has taken on my family and my work for our foundation and on me leads me to where I am today - finished with this nonsense."

USADA will almost certainly treat Armstrong's decision as an admission of guilt, and hang the label of drug cheat on an athlete who was a hero to thousands for overcoming life-threatening testicular cancer and for his foundation's support for cancer research.

The agency can impose a lifetime ban and recommend Armstrong be stripped of his titles. That would put the question in the hands of the International Cycling Union, which has disputed USADA's authority to pursue the investigation and Tour de France officials, who have had a prickly relationship with Armstrong over the years.

Armstrong insisted his decision is not an admission of drug use, but a refusal to enter an arbitration process he believes is improper and unfair to athletes facing charges.

"USADA cannot assert control of a professional international sport and attempt to strip my seven Tour de France titles," he said. "I know who won those seven Tours, my teammates know who won those seven Tours, and everyone I competed against knows who won those seven Tours."

USADA maintains that Armstrong has used banned substances as far back as 1996, including the blood-booster EPO and steroids as well as blood transfusions -- all to boost his performance.

The 40-year-old Armstrong walked away from the sport in 2011 without being charged following a two-year federal criminal investigation into many of the same accusations he faces from USADA. The federal probe was closed in February, but USADA announced in June it had evidence Armstrong used banned substances and methods -- and encouraged their use by teammates. The agency also said it had blood tests from 2009 and 2010 that were "fully consistent" with blood doping.

Included in USADA's evidence were emails written by Armstrong's former U.S. Postal Service teammate Floyd Landis, who was stripped of his 2006 Tour de France title after a positive drug test. Landis' emails to a USA Cycling official detailed allegations of a complex doping program on the team.

USADA also said it had 10 former Armstrong teammates ready to testify against him. Other than suggesting they include Landis and Tyler Hamilton, both of whom have admitted to doping offenses, the agency has refused to say who they are or specifically what they would say.

"There is zero physical evidence to support (the) outlandish and heinous claims. The only physical evidence here is the hundreds of (doping) controls I have passed with flying colors," Armstrong said.

Armstrong sued USADA in Austin, where he lives, in an attempt to block the case and was supported by the UCI, the sport's governing body. A judge threw out the case on Monday, siding with USADA despite questioning the agency's pursuit of Armstrong in his retirement.

"USADA's conduct raises serious questions about whether its real interest in charging Armstrong is to combat doping, or if it is acting according to less noble motives," such as politics or publicity, U.S. District Judge Sam Sparks wrote.

Now the ultra-competitive Armstrong has done something virtually unthinkable for him: He has quit before a fight is over.

"Today I turn the page. I will no longer address this issue, regardless of the circumstances. I will commit myself to the work I began before ever winning a single Tour de France title: serving people and families affected by cancer, especially those in underserved communities," Armstrong said.

Armstrong could have pressed his innocence in USADA's arbitration process, but the cyclist has said he believes most people have already made up their minds about whether he's a fraud or a persecuted hero.

It's a stunning move for an athlete who built his reputation on not only beating cancer, but forcing himself through grueling offseason workouts no one else could match, then crushing his rivals in the Alps and the Pyrenees.

Although he had already been crowned a world champion and won individual stages at the Tour de France, Armstrong was still relatively unknown in the U.S. until he won the epic race for the first time in 1999. It was the ultimate comeback tale: When diagnosed with cancer, doctors had given him less than a 50 percent chance of survival before surgery and brutal cycles of chemotherapy saved his life.

Armstrong's riveting victories, his work for cancer awareness and his gossip-page romances with rocker Sheryl Crow, fashion designer Tory Burch and actress Kate Hudson made him a figure who transcended sports.

His dominance of the Tour de France elevated the sport's popularity in America to unprecedented levels. His story and success helped sell millions of the "Livestrong" plastic yellow wrist bracelets, and enabled him to enlist lawmakers and global policymakers to promote cancer awareness and research. His Lance Armstrong Foundation has raised nearly 500 million since its founding in 1997.

Created in 2000, USADA is recognized by Congress as the official anti-doping agency for Olympic sports in the United States. Its investigators joined U.S. agents during the federal probe, and USADA chief executive Travis Tygart had dismissed Armstrong's lawsuit as an attempt at "concealing the truth." He said the agency is motivated by one goal -- exposing cheaters in sport.

Others close to Armstrong were caught up in the charges: Johan Bruyneel, the coach of Armstrong's teams, and three members of the medical staff and a consultant were also charged. Bruyneel is taking his case to arbitration, while two medical team staffers and consulting doctor Michele Ferrari didn't formally contest the charges and were issued lifetime ban by USADA. Ferrari later said he was innocent.

In a sport rife with cheaters, Armstrong has been under constant suspicion since the 1990s from those who refused to believe he was a clean rider winning cycling's premier event against a field of doped-up competition.

He had tense public disputes with USADA, the World Anti-Doping Agency, some former teammates and assistants and even Greg LeMond, the first American to win the Tour de France.

Through it all, Armstrong vigorously denied any and all hints, rumors and direct accusations he was cheating. He had the blazing personality, celebrity and personal wealth needed to fight back with legal and public relations battles to clear his name -- and he did, time after time.

Armstrong won his first Tour at a time when doping scandals had rocked the race. He was leading the race when a trace amount of a banned anti-inflammatory corticosteroid was found in his urine; cycling officials said he was authorized to use a small amount of a cream to treat saddle sores.

After Armstrong's second victory in 2000, French judicial officials investigated his Postal Service team for drug use. That investigation ended with no charges, but the allegations kept coming.

Armstrong was criticized for his relationship with Ferrari, who was banned by Italian authorities over doping charges in 2002. Former personal and team assistants accused Armstrong of having steroids in an apartment in Spain and disposing of syringes that were used for injections.

In 2004, a Dallas-based promotions company initially refused to pay him a 5 million bonus for winning his sixth Tour de France because it wanted to investigate allegations raised by media in Europe. Testimony in that case included former teammate Frankie Andreu and his wife, Betsy, saying Armstrong told doctors during his 1996 cancer treatments that he had taken a cornucopia of steroids and performance-enhancing drugs.

Two books published in Europe, "L.A. Confidential" and "L.A. Official," also raised doping allegations and, in 2005, French magazine L'Equipe reported that retested urine samples from the 1999 Tour showed EPO use.

Armstrong fought every accusation with denials and, in some cases, lawsuits against the European media outlets that reported them.

But he showed signs that he was tiring of the never-ending questions. Armstrong retired (for the first time) in 2005 and almost immediately considered a comeback before deciding to stay on the sidelines, in part, because he didn't want to keep answering doping questions.

"I'm sick of this," Armstrong said in 2005. "Sitting here today, dealing with all this stuff again, knowing if I were to go back, there's no way I could get a fair shake -- on the roadside, in doping control, or the labs."

But three years later, Armstrong was 36 and itching to ride again. He came back to finish third in the 2009 Tour de France.

Armstrong raced in the Tour again in 2010, under the cloud of the federal criminal investigation. Early last year, he quit the sport for good, but made a brief return as a triathlete until the USADA investigation shut him down.

During his sworn testimony in the dispute over the 5 million bonus, Armstrong said he wouldn't take performance enhancing drugs because he had too much to lose.

"(The) faith of all the cancer survivors around the world. Everything I do off the bike would go away, too," Armstrong said then. "And don't think for a second I don't understand that. It's not about money for me. Everything. It's also about the faith that people have put in me over the years. So all of that would be erased."

Quick Links

American League All-Star Game Roster Projection: AL will be loaded once again

american_league_usat.jpg
USA Today Sports Images

American League All-Star Game Roster Projection: AL will be loaded once again

The 2018 Major League All-Star Game is less than a month away. Fan votes are well underway and early frontrunners are close to locking their position in the Midsummer Classic.

Yesterday, we projected how the National League roster will play out. Today it is time to look at the American League roster projection.

For five straight seasons, the AL has had the upper hand in the MLB All-Star Game. In 2018, it does not appear that will change as the American League roster will be loaded from top to bottom.

As a reminder, here is how the process shakes out, first with the fan vote, players’ ballots, and the MLB Commissioner’s Office:

  • Fan vote: nine position players in AL (DH)/ eight in NL; plus final vote for each league
  • Player’s ballots: next 17 players in AL/ 16 players in NL; (five starting pitchers, three relievers must be chosen)
  • MLB Commissioner’s Office: five AL players (four pitchers, one position player) and seven NL players (four pitchers, three position players)

One player from each team must make the initial roster (before injury withdraws, etc.). Below is how it looks the American League roster will play out, considering the latest fan vote returns:

American League All-Star Roster Projection:

C – Wilson Ramos, Rays (Fan Vote), Gary Sánchez, Yankees (Player Ballot)
1B – José Abreu, White Sox (Fan Vote), Joey Gallo, Rangers (Player Ballot)
2B – Jose Altuve, Astros (Fan Vote), Jed Lowrie, Athletics (Player Ballot)
3B – José Ramírez, Indians (Fan Vote), Yangervis Solarte, Blue Jays (Player Ballot), Mike Moustakas, Royals (Commissioner’s Office)
SS – Manny Machado, Orioles (Fan Vote), Jean Segura, Mariners (Player Ballot),
OF – Mookie Betts, Red Sox (Fan Vote), Mike Trout, Angels (Fan Vote), Aaron Judge, Yankees (Fan Vote), Michael Brantley, Indians (Player Ballot), Eddie Rosario, Twins (Player Ballot), Giancarlo Stanton, Yankees (Player Ballot),
DH – J.D. Martinez, Red Sox (Fan Vote), Shohei Ohtani, Angels (Player Ballot)

SP – Justin Verlander, Astros (Player Ballot), Luis Severino, Yankees (Player Ballot), Corey Kluber, Indians (Player Ballot), Chris Sale, Red Sox (Player Ballot), Gerrit Cole, Astros (Player Ballot), Blake Snell, Tampa Bay (Commissioner’s Office)

RP – Edwin Díaz, Mariners (Player Ballot), Craig Kimbrel, Red Sox (Player Ballot), Aroldis Chapman, Yankees (Player Ballot), Joe Jiménez, Tigers (Commissioner’s Office), Delin Betances, Yankees (Commissioner’s Office), Chris Devenski, Astros (Commissioner’s Office)

Manager: Jeff Luhnow, Astros

Based on this projection, the New York Yankees will have the most representatives with six. The Houston Astros and Boston Red Sox will both have four.

Ensuring no snubs, there will be five players selected for the final fan vote to get one more All-Star into the game for a total of 32 for the American League. As you can see, no matter how the AL roster plays out, it will be a dominant team once again as they look for six straight All-Star wins.

Four of those five wins were inside a National League stadium and that will not change as the Washington Nationals will host this season.

MORE ALL-STAR NEWS:

Quick Links

Capitals don't get Penguins for home opener, but Penguins will host Capitals in theirs

usatsi_10824378.jpg
USA TODAY Sports

Capitals don't get Penguins for home opener, but Penguins will host Capitals in theirs

The Capitals found out who their opponent will be for the home opener on Oct. 3 and it's not the Pittsburgh Penguins.

And you know what? That's OK. Winning the Stanley Cup was awesome and the banner raising will be an incredible scene regardless. 

Plus, the Penguins need that night off because they have to get ready for their own home opener on Oct. 4 against...the Caps?

Wait, what?

In 2016, the Capitals were in attendance as the Penguins raised their Stanley Cup banner. That had to sting considering Pittsburgh eliminated Washington in the playoffs.

It has not become a tradition to make rivals watch as teams raise banners and there's nothing that said the NHL had to schedule the Penguins for Washington's home opener. But it does seem odd that the NHL is going to make the defending Stanley Cup champions play a back-to-back right out of the gate with the second end coming against their archrivals in Pittsburgh.

Hey Caps, it's the NHL here. Congrats again. Vegas is a hell of a city, am I right? So, listen...we thought about it and decided you won't get to raise your banner against your rivals. Sorry about that. We tried and we couldn't get them for your first game. Good news though, we moved it all the way up to the second game, we just couldn't get it any sooner than that. You'll be playing them the second game of the season...the night after your home opener...in Pittsburgh...for their home opener. Anyway, good luck on the repeat.

Makes sense.

Look, if Washington can't have Pittsburgh for the home opener fine. It would have been nice, but it's really not a big deal. Raising the banner will be special regardless of who the opponent will be. But don't turn around and make the Caps play in the Penguins' home opener the very next day.

The schedule makers did the Caps no favors with this one.

MORE CAPITALS COVERAGE: